• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两例小儿溃疡性结肠炎患者的粪便微生物群移植:肠道微生物群与临床病程的相关性

Fecal Microbiota Transplant in Two Ulcerative Colitis Pediatric Cases: Gut Microbiota and Clinical Course Correlations.

作者信息

Quagliariello Andrea, Del Chierico Federica, Reddel Sofia, Russo Alessandra, Onetti Muda Andrea, D'Argenio Patrizia, Angelino Giulia, Romeo Erminia Francesca, Dall'Oglio Luigi, De Angelis Paola, Putignani Lorenza

机构信息

Area of Genetics and Rare Diseases, Unit of Human Microbiome, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.

Department of Laboratories, Unit of Parasitology, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.

出版信息

Microorganisms. 2020 Sep 27;8(10):1486. doi: 10.3390/microorganisms8101486.

DOI:10.3390/microorganisms8101486
PMID:32992653
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7599854/
Abstract

Fecal microbiota transplantation (FMT) is a promising strategy in the management of inflammatory bowel disease (IBD). The clinical effects of this practice are still largely unknown and unpredictable. In this study, two children affected by mild and moderate ulcerative colitis (UC), were pre- and post-FMT monitored for clinical conditions and gut bacterial ecology. Microbiota profiling relied on receipts' time-point profiles, donors and control cohorts' baseline descriptions. After FMT, the improvement of clinical conditions was recorded for both patients. After 12 months, the mild UC patient was in clinical remission, while the moderate UC patient, after 12 weeks, had a clinical worsening. Ecological analyses highlighted an increase in microbiota richness and phylogenetic distance after FMT. This increase was mainly due to and , inherited by respective donors. Moreover, a decrease of and , and the increment of , , , , , and were associated with remission of the patient's condition. FMT results in a long-term response in mild UC, while in the moderate form there is probably need for multiple FMT administrations. FMT leads to a decrease in potential pathogens and an increase in microorganisms correlated to remission status.

摘要

粪便微生物群移植(FMT)是治疗炎症性肠病(IBD)的一种有前景的策略。这种治疗方法的临床效果在很大程度上仍然未知且不可预测。在本研究中,对两名患有轻度和中度溃疡性结肠炎(UC)的儿童在FMT前后进行了临床状况和肠道细菌生态学监测。微生物群分析依赖于接受者的时间点概况、供体和对照队列的基线描述。FMT后,两名患者的临床状况均有改善。12个月后,轻度UC患者处于临床缓解期,而中度UC患者在12周后临床病情恶化。生态学分析表明,FMT后微生物群丰富度和系统发育距离增加。这种增加主要归因于分别从各自供体继承的 和 。此外, 和 的减少以及 、 、 、 、 和 的增加与患者病情缓解相关。FMT在轻度UC中可产生长期反应,而在中度UC中可能需要多次进行FMT。FMT导致潜在病原体减少,与缓解状态相关的微生物增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aefc/7599854/f5afead8fb34/microorganisms-08-01486-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aefc/7599854/147bac1e7dc8/microorganisms-08-01486-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aefc/7599854/07fd6aa4c0af/microorganisms-08-01486-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aefc/7599854/f5afead8fb34/microorganisms-08-01486-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aefc/7599854/147bac1e7dc8/microorganisms-08-01486-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aefc/7599854/07fd6aa4c0af/microorganisms-08-01486-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aefc/7599854/f5afead8fb34/microorganisms-08-01486-g003.jpg

相似文献

1
Fecal Microbiota Transplant in Two Ulcerative Colitis Pediatric Cases: Gut Microbiota and Clinical Course Correlations.两例小儿溃疡性结肠炎患者的粪便微生物群移植:肠道微生物群与临床病程的相关性
Microorganisms. 2020 Sep 27;8(10):1486. doi: 10.3390/microorganisms8101486.
2
A Matching Strategy To Guide Donor Selection for Ulcerative Colitis in Fecal Microbiota Transplantation: Meta-Analysis and Analytic Hierarchy Process.一种用于粪菌移植治疗溃疡性结肠炎的供体选择匹配策略:荟萃分析和层次分析法。
Microbiol Spectr. 2023 Feb 14;11(1):e0215921. doi: 10.1128/spectrum.02159-21. Epub 2022 Dec 6.
3
Fecal microbiota transplantation ameliorates active ulcerative colitis.粪便微生物群移植可改善活动性溃疡性结肠炎。
Exp Ther Med. 2020 Apr;19(4):2650-2660. doi: 10.3892/etm.2020.8512. Epub 2020 Feb 11.
4
Fecal Microbiota Transplantation in Experimental Ulcerative Colitis Reveals Associated Gut Microbial and Host Metabolic Reprogramming.粪便微生物移植在实验性溃疡性结肠炎中的作用揭示了相关的肠道微生物和宿主代谢重编程。
Appl Environ Microbiol. 2018 Jul 2;84(14). doi: 10.1128/AEM.00434-18. Print 2018 Jul 15.
5
Clinical response and changes in the fecal microbiota and metabolite levels after fecal microbiota transplantation in patients with inflammatory bowel disease and recurrent infection.炎症性肠病和反复感染患者粪便微生物群移植后的临床反应、粪便微生物群及代谢物水平变化
Fujita Med J. 2021;7(3):87-98. doi: 10.20407/fmj.2020-021. Epub 2020 Nov 13.
6
A Two-Week Fecal Microbiota Transplantation Course in Pediatric Patients with Inflammatory Bowel Disease.两周粪便微生物群移植疗程在小儿炎症性肠病患者中的应用。
Adv Exp Med Biol. 2018;1047:81-87. doi: 10.1007/5584_2017_123.
7
Fecal microbiota transplantation results in bacterial strain displacement in patients with inflammatory bowel diseases.粪便微生物群移植可导致炎症性肠病患者的细菌菌株置换。
FEBS Open Bio. 2020 Jan;10(1):41-55. doi: 10.1002/2211-5463.12744. Epub 2019 Dec 13.
8
Long-Term Efficacy of Low-Intensity Single Donor Fecal Microbiota Transplantation in Ulcerative Colitis and Outcome-Specific Gut Bacteria.低强度单供体粪便微生物群移植治疗溃疡性结肠炎的长期疗效及特定结局肠道细菌
Front Microbiol. 2021 Nov 17;12:742255. doi: 10.3389/fmicb.2021.742255. eCollection 2021.
9
Cross-Talk Between Butyric Acid and Gut Microbiota in Ulcerative Colitis Following Fecal Microbiota Transplantation.粪便微生物群移植后溃疡性结肠炎中丁酸与肠道微生物群的相互作用
Front Microbiol. 2021 Apr 12;12:658292. doi: 10.3389/fmicb.2021.658292. eCollection 2021.
10
Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis.与溃疡性结肠炎患者对粪便微生物群移植的反应相关的特定细菌和代谢物。
Gastroenterology. 2019 Apr;156(5):1440-1454.e2. doi: 10.1053/j.gastro.2018.12.001. Epub 2018 Dec 6.

引用本文的文献

1
Culture-based characterization of gut microbiota in inflammatory bowel disease.基于培养的炎症性肠病肠道微生物群特征分析
Front Microbiol. 2025 Feb 20;16:1538620. doi: 10.3389/fmicb.2025.1538620. eCollection 2025.
2
Host-microbe multi-omics and succinotype profiling have prognostic value for future relapse in patients with inflammatory bowel disease.宿主-微生物多组学和琥珀酸型分析对炎症性肠病患者未来复发具有预后价值。
Gut Microbes. 2025 Dec;17(1):2450207. doi: 10.1080/19490976.2025.2450207. Epub 2025 Jan 15.
3
A Review of Fecal Microbiota Transplantation in Children-Exploring Its Role in the Treatment of Inflammatory Bowel Diseases.

本文引用的文献

1
Fecal microbiota transplantation ameliorates active ulcerative colitis.粪便微生物群移植可改善活动性溃疡性结肠炎。
Exp Ther Med. 2020 Apr;19(4):2650-2660. doi: 10.3892/etm.2020.8512. Epub 2020 Feb 11.
2
Fecal transplantation for ulcerative colitis: current evidence and future applications.粪便移植治疗溃疡性结肠炎:现有证据和未来应用。
Expert Opin Biol Ther. 2020 Apr;20(4):343-351. doi: 10.1080/14712598.2020.1733964. Epub 2020 Feb 26.
3
Acceptability, tolerability, and safety of fecal microbiota transplantation in patients with active ulcerative colitis (AT&S Study).
粪菌移植在儿童中的应用综述——探索其在炎症性肠病治疗中的作用。
Medicina (Kaunas). 2024 Nov 20;60(11):1899. doi: 10.3390/medicina60111899.
4
Gut Microbiome and Pulmonary Arterial Hypertension - A Novel and Evolving Paradigm.肠道微生物组与肺动脉高压——一个新颖而不断发展的范式。
Physiol Res. 2024 Nov 29;73(S2):S477-S485. doi: 10.33549/physiolres.935430.
5
Fecal Microbiota Transplantation for Recurrent Infections in a Cystic Fibrosis Child Previously Screen Positive, Inconclusive Diagnosis (CFSPID): A Case Report.粪菌移植治疗一名先前筛查呈阳性、诊断不确定(CFSPID)的囊性纤维化儿童复发性感染:病例报告
Microorganisms. 2024 Oct 12;12(10):2059. doi: 10.3390/microorganisms12102059.
6
Colonization of microbiota derived from s, Bama miniature pigs, beagle dogs, and C57BL/6J mice alleviates DSS-induced colitis in germ-free mice.源自巴马小型猪、比格犬和C57BL/6J小鼠的微生物群在无菌小鼠中定殖可减轻葡聚糖硫酸钠诱导的结肠炎。
Microbiol Spectr. 2024 Jul 11;12(8):e0038824. doi: 10.1128/spectrum.00388-24.
7
Complementary Therapeutic Effect of Fecal Microbiota Transplantation in Ulcerative Colitis after the Response to Anti-Tumor Necrosis Factor Alpha Agent Was Lost: A Case Report.抗肿瘤坏死因子α药物反应消失后粪便微生物群移植对溃疡性结肠炎的辅助治疗作用:一例报告
Biomedicines. 2024 Apr 3;12(4):800. doi: 10.3390/biomedicines12040800.
8
Age-related effects on the modulation of gut microbiota by pectins and their derivatives: an study.果胶及其衍生物对肠道微生物群调节的年龄相关影响:一项研究。
Front Microbiol. 2023 Jul 5;14:1207837. doi: 10.3389/fmicb.2023.1207837. eCollection 2023.
9
Therapeutic Perspectives for Microbiota Transplantation in Digestive Diseases and Neoplasia-A Literature Review.消化系统疾病和肿瘤中微生物群移植的治疗前景——文献综述
Pathogens. 2023 May 26;12(6):766. doi: 10.3390/pathogens12060766.
10
The Hypolipidemic Effect of Hawthorn Leaf Flavonoids through Modulating Lipid Metabolism and Gut Microbiota in Hyperlipidemic Rats.山楂叶黄酮通过调节高脂血症大鼠脂质代谢和肠道菌群发挥降血脂作用
Evid Based Complement Alternat Med. 2022 Nov 15;2022:3033311. doi: 10.1155/2022/3033311. eCollection 2022.
粪便微生物群移植在活动性溃疡性结肠炎患者中的可接受性、耐受性和安全性(AT&S研究)。
J Gastroenterol Hepatol. 2020 Mar;35(3):418-424. doi: 10.1111/jgh.14829. Epub 2019 Sep 1.
4
Fecal microbiota transplantation: great potential with many challenges.粪便微生物群移植:潜力巨大但挑战众多。
Transl Gastroenterol Hepatol. 2019 May 25;4:40. doi: 10.21037/tgh.2019.05.10. eCollection 2019.
5
Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial.粪便微生物移植对溃疡性结肠炎患者 8 周缓解的影响:一项随机临床试验。
JAMA. 2019 Jan 15;321(2):156-164. doi: 10.1001/jama.2018.20046.
6
Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children: A Joint Position Paper From the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition.粪便微生物移植治疗儿童复发性艰难梭菌感染和其他疾病:北美儿童胃肠病学、肝病学和营养学学会与欧洲儿童胃肠病学、肝病学和营养学学会联合立场文件。
J Pediatr Gastroenterol Nutr. 2019 Jan;68(1):130-143. doi: 10.1097/MPG.0000000000002205.
7
Fecal transplantation for treatment of inflammatory bowel disease.粪便移植治疗炎症性肠病。
Cochrane Database Syst Rev. 2018 Nov 13;11(11):CD012774. doi: 10.1002/14651858.CD012774.pub2.
8
Gut Microbiome in Inflammatory Bowel Disease and Other Chronic Immune-Mediated Inflammatory Diseases.炎症性肠病及其他慢性免疫介导性炎症疾病中的肠道微生物群
Inflamm Intest Dis. 2017 Nov;2(2):116-123. doi: 10.1159/000481401. Epub 2017 Oct 20.
9
Fecal Microbiota Transplantation for Primary Clostridium difficile Infection.粪便微生物群移植治疗原发性艰难梭菌感染
N Engl J Med. 2018 Jun 28;378(26):2535-2536. doi: 10.1056/NEJMc1803103. Epub 2018 Jun 2.
10
Inflammatory bowel disease and immunonutrition: novel therapeutic approaches through modulation of diet and the gut microbiome.炎症性肠病与免疫营养:通过饮食和肠道微生物组调节的新型治疗方法。
Immunology. 2018 Sep;155(1):36-52. doi: 10.1111/imm.12939. Epub 2018 May 16.